These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 23910171)

  • 1. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).
    Vijgen SM; Boers KE; Opmeer BC; Bijlenga D; Bekedam DJ; Bloemenkamp KW; de Boer K; Bremer HA; le Cessie S; Delemarre FM; Duvekot JJ; Hasaart TH; Kwee A; van Lith JM; van Meir CA; van Pampus MG; van der Post JA; Rijken M; Roumen FJ; van der Salm PC; Spaanderman ME; Willekes C; Wijnen EJ; Mol BW; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):358-63. PubMed ID: 23910171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which intrauterine growth restricted fetuses at term benefit from early labour induction? A secondary analysis of the DIGITAT randomised trial.
    Tajik P; van Wyk L; Boers KE; le Cessie S; Zafarmand MH; Roumen F; van der Post JA; Porath M; van Pampus MG; Spaanderdam ME; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; van Lith JM; Bossuyt PM; Mol BW; Scherjon SA;
    Eur J Obstet Gynecol Reprod Biol; 2014 Jan; 172():20-5. PubMed ID: 24192662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic analysis comparing induction of labor and expectant management in women with preterm prelabor rupture of membranes between 34 and 37 weeks (PPROMEXIL trial).
    Vijgen SM; van der Ham DP; Bijlenga D; van Beek JJ; Bloemenkamp KW; Kwee A; Groenewout M; Kars MM; Kuppens S; Mantel G; Molkenboer JF; Mulder AL; Nijhuis JG; Pernet PJ; Porath M; Woiski MD; Weinans MJ; van Wijngaarden WJ; Wildschut HI; Akerboom B; Sikkema JM; Willekes C; Mol BW; Opmeer BC;
    Acta Obstet Gynecol Scand; 2014 Apr; 93(4):374-81. PubMed ID: 24392746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal morbidity after induction vs expectant monitoring in intrauterine growth restriction at term: a subanalysis of the DIGITAT RCT.
    Boers KE; van Wyk L; van der Post JA; Kwee A; van Pampus MG; Spaanderdam ME; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; Rijken M; Roumen FJ; Thornton JG; van Lith JM; Mol BW; le Cessie S; Scherjon SA;
    Am J Obstet Gynecol; 2012 Apr; 206(4):344.e1-7. PubMed ID: 22342897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction versus expectant monitoring for intrauterine growth restriction at term: randomised equivalence trial (DIGITAT).
    Boers KE; Vijgen SM; Bijlenga D; van der Post JA; Bekedam DJ; Kwee A; van der Salm PC; van Pampus MG; Spaanderman ME; de Boer K; Duvekot JJ; Bremer HA; Hasaart TH; Delemarre FM; Bloemenkamp KW; van Meir CA; Willekes C; Wijnen EJ; Rijken M; le Cessie S; Roumen FJ; Thornton JG; van Lith JM; Mol BW; Scherjon SA;
    BMJ; 2010 Dec; 341():c7087. PubMed ID: 21177352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionate Intrauterine Growth Intervention Trial At Term: DIGITAT.
    Boers KE; Bijlenga D; Mol BW; LeCessie S; Birnie E; van Pampus MG; Stigter RH; Bloemenkamp KW; van Meir CA; van der Post JA; Bekedam DJ; Ribbert LS; Drogtrop AP; van der Salm PC; Huisjes AJ; Willekes C; Roumen FJ; Scheepers HC; de Boer K; Duvekot JJ; Thornton JG; Scherjon SA
    BMC Pregnancy Childbirth; 2007 Jul; 7():12. PubMed ID: 17623077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
    Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
    BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine growth restriction at term: induction or spontaneous labour? Disproportionate intrauterine growth intervention trial at term (DIGITAT): a pilot study.
    van den Hove MM; Willekes C; Roumen FJ; Scherjon SA
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):54-8. PubMed ID: 16054286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects on (neuro)developmental and behavioral outcome at 2 years of age of induced labor compared with expectant management in intrauterine growth-restricted infants: long-term outcomes of the DIGITAT trial.
    van Wyk L; Boers KE; van der Post JA; van Pampus MG; van Wassenaer AG; van Baar AL; Spaanderdam ME; Becker JH; Kwee A; Duvekot JJ; Bremer HA; Delemarre FM; Bloemenkamp KW; de Groot CJ; Willekes C; Roumen FJ; van Lith JM; Mol BW; le Cessie S; Scherjon SA;
    Am J Obstet Gynecol; 2012 May; 206(5):406.e1-7. PubMed ID: 22444791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II).
    van Baaren GJ; Broekhuijsen K; van Pampus MG; Ganzevoort W; Sikkema JM; Woiski MD; Oudijk MA; Bloemenkamp K; Scheepers H; Bremer HA; Rijnders R; van Loon AJ; Perquin D; Sporken J; Papatsonis D; van Huizen ME; Vredevoogd CB; Brons J; Kaplan M; van Kaam AH; Groen H; Porath M; van den Berg PP; Mol B; Franssen M; Langenveld J;
    BJOG; 2017 Feb; 124(3):453-461. PubMed ID: 26969198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of planned immediate versus delayed birth for preterm prelabour rupture of membranes: findings from the PPROMT randomised controlled trial.
    Lain SJ; Roberts CL; Bond DM; Smith J; Morris JM
    BJOG; 2017 Mar; 124(4):623-630. PubMed ID: 27770483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of induction of labour versus serial antenatal monitoring in the Canadian Multicentre Postterm Pregnancy Trial.
    Goeree R; Hannah M; Hewson S
    CMAJ; 1995 May; 152(9):1445-50. PubMed ID: 7728693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. More Maternal Vascular Malperfusion and Chorioamnionitis in Placentas After Expectant Management vs. Immediate Delivery in Fetal Growth Restriction at (Near) Term: A Further Analysis of the DIGITAT Trial.
    Feenstra ME; Schoots MH; Plösch T; Prins JR; Scherjon SA; Timmer A; van Goor H; Gordijn SJ
    Front Endocrinol (Lausanne); 2019; 10():238. PubMed ID: 31105647
    [No Abstract]   [Full Text] [Related]  

  • 14. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
    Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
    BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial).
    Shennan A; Hezelgrave N
    BJOG; 2010 Dec; 117(13):1575-6. PubMed ID: 21125706
    [No Abstract]   [Full Text] [Related]  

  • 16. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial).
    Vijgen SM; Koopmans CM; Opmeer BC; Groen H; Bijlenga D; Aarnoudse JG; Bekedam DJ; van den Berg PP; de Boer K; Burggraaff JM; Bloemenkamp KW; Drogtrop AP; Franx A; de Groot CJ; Huisjes AJ; Kwee A; van Loon AJ; Lub A; Papatsonis DN; van der Post JA; Roumen FJ; Scheepers HC; Stigter RH; Willekes C; Mol BW; Van Pampus MG;
    BJOG; 2010 Dec; 117(13):1577-85. PubMed ID: 20840526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women.
    Einerson BD; Nelson RE; Sandoval G; Esplin MS; Branch DW; Metz TD; Silver RM; Grobman WA; Reddy UM; Varner M;
    Obstet Gynecol; 2020 Jul; 136(1):19-25. PubMed ID: 32541288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal health-related quality of life after induction of labor or expectant monitoring in pregnancy complicated by intrauterine growth retardation beyond 36 weeks.
    Bijlenga D; Boers KE; Birnie E; Mol BW; Vijgen SC; Van der Post JA; De Groot CJ; Rijnders RJ; Pernet PJ; Roumen FJ; Stigter RH; Delemarre FM; Bremer HA; Porath M; Scherjon SA; Bonsel GJ
    Qual Life Res; 2011 Nov; 20(9):1427-36. PubMed ID: 21468753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of induction of labour at term with a Foley catheter compared to vaginal prostaglandin E₂ gel (PROBAAT trial).
    van Baaren GJ; Jozwiak M; Opmeer BC; Oude Rengerink K; Benthem M; Dijksterhuis MG; van Huizen ME; van der Salm PC; Schuitemaker NW; Papatsonis DN; Perquin DA; Porath M; van der Post JA; Rijnders RJ; Scheepers HC; Spaanderman M; van Pampus MG; de Leeuw JW; Mol BW; Bloemenkamp KW
    BJOG; 2013 Jul; 120(8):987-95. PubMed ID: 23530729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.